Strides Arcolab (Strides) has received approval from the US FDA for Vancomycin Hydrochloride Capsules USP, 125 mg and 250 mg. Vancomycin Capsules had total US sales of $32 million for the twelve months ending February 2012, with no prior generic approvals.
Vancomycin Hydrochloride Capsules is glycopeptides antibiotic used in the prophylaxis and treatment of infections caused by Gram positive bacteria. It has traditionally been reserved as a drug of last resort used only after treatment with other antibiotics had failed.
Strides Arcolab is a global pharmaceuticals headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceuticals products with an emphasis on sterile injectables.
